IL17A and colitis: Kawano et al. (2015), using an in vivo DSS-induced colitis model in C57BL/6 mice, reported that BRB reduced Th1/Th17 lymphocyte populations and the associated cytokines (TNF-α and IL-17), consistent with earlier studies [50].